期刊文献+

微小RNA-150在肝细胞癌中的表达及其临床意义

Expression and clinical significance of mi R-150 in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨微小RNA(mi R)-150在肝细胞癌中的表达及其临床意义。方法实时荧光定量聚合酶链反应(q RT-PCR)检测肝癌及配对癌旁组织中mi R-150表达。原位杂交技术(ISH)进一步验证肝癌和配对癌旁组织mi R-150表达差异。将肝癌组织中mi R-150表达与临床病理特征进行关联分析。Kaplan-Meier法检测mi R-150阴性组和阳性组生存曲线。Cox单因素回归模型分析mi R-150表达与患者术后总生存的相关性。结果 q RT-PCR结果显示:与癌旁组织相比,12例中有8例肝癌组织低表达mi R-150,肝癌组织中mi R-150表达明显降低(P=0.034)。ISH结果与q RT-PCR结果相一致,即肝癌组织大部分为阴性或弱阳性表达,62%癌旁组织ISH染色强度高于配对的肝癌组织(P<0.001)。关联分析提示mi R-150表达与AFP、肿瘤大小、TNM分期、组织学分级、脉管癌栓存在明显负相关(P<0.05)。mi R-150阳性组患者术后总生存明显高于mi R-150阴性组(P=0.004,Kaplan-Meier法)。Cox单因素回归分析提示肝癌组织低表达mi R-150是患者不良预后指标(P=0.005)。结论肝癌组织低表达mi R-150与肿瘤侵袭表型相关,提示不良预后。 Objectives To investigate the expression and clinical significance of mi R-150 in hepatocellular carcinoma(HCC). Methods mi R-150 expression in liver cancer and paired normal tumor-adjacent tissues was determined by quantitative Real-time PCR(q RT-PCR). The expression difference between HCC and tumor-adjacent tissues was further verified using in situ hybrization(ISH)technique. Association of mi R-150 expression in HCC tissues with clinicopathological status was examined by correlation analysis. Prognostic significance of mi R-150 expression in HCC samples was detected with Kaplan-Meier method and Cox regression analysis. Results q RT-PCR assay showed 8 /12 HCC cases had lower mi R-150 expression compared with tumor-adjacent tissues and mi R-150 expression level in HCC tissues markedly decreased(P =0.034). Similar to q RT-PCR results, ISH technique demonstrated most HCC specimens had negative or weak staining of mi R-150, and staining intensity in 62% tumor-adjacent tissues was much higher than that in paired HCC tissues(P〈0.001).Correlation analysis suggested mi R-150 expression was significantly negatively correlated with AFP level, tumor size, TNM stage, histological grade and intravascular thrombus(P 0.05). Postoperative overall survival(OS) of mi R-150 positive group was much longer that of mi R-150 negative group(P =0.004, Kaplan-Meier method). Cox univariate regression analysis implicated low mi R-150 level in HCC samples was an unfavorable prognostic indicator(P=0.005). Conclusion Low expression of mi R-150 in HCC specimens is related with a more aggressive tumor phenotype and indicates poor prognosis for HCC patients.
出处 《岭南现代临床外科》 2015年第4期381-384,共4页 Lingnan Modern Clinics in Surgery
基金 广东省科技计划国际合作项目(2012B050 600014) 梅州市科技计划项目(2014B142)
关键词 微小RNA-150 肝细胞癌 预后 Micro RNA-150 Hepatocellular carcinoma Prognosis
  • 相关文献

参考文献8

  • 1Calin CA, Croce CM. MicroRNA signatures in human cancers [J]. Nat Rev Cancer, 2006, 6(11): 857-866.
  • 2Budhu A, Jia HL, Forgues M, et al. Identification of metastasis- related microRNAs in hepatocellular carcinoma[J]. Hepatology, 2008, 47 (3) : 897-907.
  • 3李杰,刘涛,杜振宁,蔡腾,张丰泉.微小RNA-146a在骨肉瘤中的表达及意义[J].中华实验外科杂志,2015,32(2):419-421. 被引量:6
  • 4Wu Q, Jin H, Yang Z, et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2 [J]. Biochem Biophys Res Commun, 2010, 392 (3) : 340-345.
  • 5Li T, Xie J, Shen C, et al. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14[J]. PLoS One, 2014, 9(12): e115577.
  • 6Yin QW, Sun XF, Yang GT, et al. Increased expression of microRNA-150 is associated with poor prognosis in non- small cell lung cancer [J]. Int J Clin Exp Pathol, 2015, 8 ( 1 ) : 842-846.
  • 7Dezhong L, Xiaoyi Z, Xianlian L, et al. miR-150 is a factor of survival in prostate cancer patients[J]. J BUON, 2015, 20(1): 173-179.
  • 8Jin M, Yang Z, Ye W, et al. MicroRNA-150 predicts a favorable prognosis in patients witb epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1 [J]. PLoS One, 2014, 9(8) : e103965.

二级参考文献10

  • 1Hameed M, Dorfman H. Primary malignant bone tumors-recent devel-opments [J]. Semin Diagn Pathol,2011 ,28( 1 ) :86-101.
  • 2Siclari VA,Qin L. Targeting the osteosarcoma cancer stem cell[ J]. JOrthop Surg Res,2010,5 :78.
  • 3Steinmann P, Walters DK, Arlt MJ, et al. Antimetastatic activity ofhonokiol in osteosarcoma[ J]. Cancer,2012,118(8) :2117-2127.
  • 4Broadhead ML,Clark JC,Myers DE,et al. The molecular pathogenesisof osteosarcoma:a reviewf J]. Sarcoma,2011 ,9(5) :248.
  • 5Dong Y,Yu J,Ng SS. MicroRNA dysregulation as a prognostic bio-marker in colorectal cancer[ J]. Cancer Manag Rest2014,6(3) :405-422.
  • 6Stefani G, Slack FJ. Small non-coding RNAs in animal development[J]. Nat Rev Mol Cell Biol ,2008 ,9(3) :219-230.
  • 7Calin GA, Dumitru CD , Shimizu M, et al. Frequent deletions anddown-regulation of micro-RNA genes miR15 and miR!6 at 13ql4 inchronic lymphocytic leukemia[ J]. Proc Natl Acad Sci U S A,2002,99(24) :15524-15529.
  • 8Esquela-Kerscher A,Slack FJ. Oncomirs-microRNAs with a role incancer[ J]. Nat Rev Cancer,2006 ,6(4) :259-269.
  • 9Li Y,Zhang J,Zhang L,et al. Diallyl trisulfide inhibits proliferation,invasion and angiogenesis of osteosarcoma cells by switching on sup-pressor microRNAs and inactivating of Notch-1 signaling [ J ]. Carcino-genesis ,2013,34 (7) :1601-1610.
  • 10Shi Y,Lee JS,Galvin KM. Everything you have ever wanted to knowabout Yin Yang 1 [J]. Biochim Biophys Acta, 1997 ,1332 (2 ) : F49-F66.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部